Telomerase: 540-548 Peptide Vaccine
A recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT). Telomerase expression has been directly linked to tumor development; its catalytic subunit is expressed in the majority of human cancer cells, but infrequently in normal cells. Vaccination with telomerase:540-548 peptide may stimulate cytotoxic T cells to recognize and kill telomerase-expressing cells. (NCI04) [ ]
Term info
Telomerase: 540-548 Peptide Vaccine
- Telomerase: 540-548 Peptide Vaccine
- Telomerase:540-548 Peptide
NCIT_C128784
Telomerase_540-548_Peptide_Vaccine
720002
38362
Telomerase: 540-548 Peptide Vaccine
Pharmacologic Substance, Immunologic Factor
C0935896
C2640
Term relations
- Antineoplastic Vaccine
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation